Multiple Choice
A current problem in modern medicine is the development of drug resistance mutations.This occurs when a mutation arises in a disease-causing microbe making it resistant to a drug and thus rendering the drug useless in treating a specific disease.Many useful drugs are competitive inhibitors of specific enzymes,and the drug-resistance mutations prevent the binding of the drug.These types of mutations,in addition to preventing competitive inhibitor binding,can also sometimes reduce the activity of the enzyme.Why is that the case?
A) Binding to the competitive inhibitor is essential for the function of the enzyme
B) These mutations most likely affect an allosteric site on the enzyme
C) These mutations lower the activation energy of the reaction catalyzed by the enzyme
D) These mutations most likely change the shape of the active site of the enzyme
Correct Answer:

Verified
Correct Answer:
Verified
Q41: Under standard conditions,ATP can release for every
Q42: Enzyme 1 converts substrate A into product
Q43: In the hypothetical biochemical pathway,P → Q
Q44: The energy needed to destabilize existing chemical
Q45: If the ΔG of a reaction was
Q47: Hexokinase is an enzyme that binds specifically
Q48: A particular chemical reaction is exergonic.What can
Q49: In a chemical reaction,glyceraldehyde-3-phosphate + NAD<sup>+</sup> yields
Q50: In an enzyme-catalyzed reaction,the reactant is called
Q51: While conducting an experiment,you realize that a